Innospec (IOSP) FY2016 results: revenue $883 million, down 12.7% on the year
Innospec Inc. (IOSP) reported revenue of $883 million for fiscal 2016, the year ended 31 December 2016, down 12.7% on the year before. Net income was $81 million, down 32.0%, and diluted earnings per share $3.33. The figures are the company's own, from the 10-K it filed with the SEC on 20 February 2019.
Revenue
$883 million
-12.7% on the year
FY2009FY2016
Operating margin
11.1%
15.4% a year earlier
FY2009FY2016
Net income
$81 million
-32.0% on the year
FY2009FY2016
Diluted EPS
$3.33
-31.5% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
883
1,012
961
-12.7%
Cost of revenue
551
666
659
-17.3%
Gross profit
332
346
302
-4.0%
Gross margin
37.6%
34.2%
31.4%
Research and development
25.4
25.3
22.2
+0.4%
Selling, general and administrative
217
207
169
+4.8%
Operating income
98.2
156
112
-37.2%
Operating margin
11.1%
15.4%
11.7%
Interest expense
2.6
2.3
3.8
+13.0%
Pre-tax income
103
152
111
-32.3%
Income tax
21.8
32.8
26.8
-33.5%
Effective tax rate
21.1%
21.5%
24.2%
Net income
81.3
120
84.1
-32.0%
Net margin
9.2%
11.8%
8.8%
Diluted EPS
$3.33
$4.86
$3.38
-31.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
106
118
106
-10.7%
Capital expenditure
16.5
17.6
13.5
-6.2%
Free cash flow
89.0
101
92.8
-11.5%
Free cash flow margin
10.1%
9.9%
9.7%
Cash from investing
-209
n/a
n/a
Cash from financing
69.5
n/a
n/a
Depreciation and amortisation
38.1
35.2
29.1
+8.2%
Share-based compensation
3.3
3.7
2.6
-10.8%
Buybacks
8.4
15.3
6.9
-45.1%
Dividends paid
15.9
14.9
13.4
+6.7%
Dividend per share
$0.67
$0.61
$0.55
+9.8%
Diluted shares, weighted
24m
25m
25m
-0.7%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
654
605
516
+8.0%
Non-controlling interest
0.3
0.3
0.0
0.0%
Debt
269
132
139
+104.3%
Other liabilities
259
293
345
-11.7%
Total liabilities and equity
1,181
1,030
1,000
+14.7%
Fixed assets
157
76.0
80.8
+107.1%
Goodwill
375
267
276
+40.2%
Intangible assets
144
169
181
-14.4%
Investments
0.0
4.8
4.7
Cash and equivalents
102
137
41.6
-25.6%
Receivables
154
137
164
+12.4%
Inventory
174
160
185
+8.7%
Other assets
74.7
78.9
66.4
-5.3%
Total assets
1,181
1,030
1,000
+14.7%
10-K for the year ended 31 December 2016, filed 20 February 2019: the filing.